RxDoctor Payments Data
★ My doctorsLook up a doctor →

Paul Perkowski, MD

Vascular Surgery · Shreveport, LANPI 1053301150

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (46.3%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Penumbra, Inc. accounts for 73.7% of it on its own, with 32 other manufacturers making up the rest. Reporting peaked in 2019 at $20,754 and has fallen 83.3% since, to $3,470 in 2025. Among vascular surgery clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$41,483in general payments, 2019–2025

Across 230 payments — averaging $180.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Penumbra, Inc.$31K
  • Medtronic$2K
  • Philips North America LLC$2K
  • Endologix LLC$744
  • Shockwave Medical, Inc$669
  • Inari Medical, Inc.$514
  • plus $5K from 27 others
$151,845in research payments, 2019–2025

Across 66 payments — averaging $2300.68 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Penumbra, Inc.$152K

What the payments were for

  • Speaking & faculty fees$19,20046%
  • Travel & lodging$6,86017%
  • Food & beverage$15,42337%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Penumbra, Inc.73$30,571
Medtronic(2 entities)35$2,432
Philips North America LLC23$1,980
Endologix LLC6$744
Shockwave Medical, Inc10$669
Inari Medical, Inc.5$514
W. L. Gore & Associates, Inc.5$461
Boston Scientific10$445
Cardiovascular Systems Inc.6$393
Silk Road Medical, Inc.7$376
GE HealthCare4$370
Kerecis Limited3$368
Acera Surgical, Inc.2$255
Siemens Medical Solutions USA, Inc.4$230
Solventum Corporation7$218
Surmodics, Inc.2$191
Johnson & Johnson(2 entities)5$166
Cardiva Medical, Inc.3$127
AbbVie1$124
Kls-martin L.p.1$123
Terumo Medical Corporation2$122
Angiodynamics, Inc.1$101
Axogen1$95
Terumo BCT, Inc.1$94
Teleflex LLC1$68
Intuitive Surgical1$62
Smith+Nephew3$47
Innovation Technologies Inc2$42
KCI USA, Inc.2$37
Lemaitre Vascular, Inc.1$17
Osiris Therapeutics Inc.1$15
Cook Medical LLC1$13
EKOS Corporation1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$41,483 in reported general payments places this provider in the 90th percentile of 65 vascular surgery providers in Louisiana.

See all vascular surgery providers in Louisiana →

Medicare billing

Part B allowed, 2024
$63,856
Medicare patients
131
Services billed
326

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cilostazol12$132

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Shreveport

See the full list for Louisiana →

Where these figures come from

Is this you, or does something look wrong? →